11/14
07:39 am
lyra
Lyra Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Medium
Report
Lyra Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
11/12
04:12 pm
lyra
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
04:01 pm
lyra
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
High
Report
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/15
07:00 am
lyra
Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis
Low
Report
Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis
9/27
07:00 am
lyra
Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
Medium
Report
Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings
9/6
06:59 am
lyra
Lyra Therapeutics, Inc. (NASDAQ: LYRA) was upgraded by analysts at William Blair to a "hold" rating.
Medium
Report
Lyra Therapeutics, Inc. (NASDAQ: LYRA) was upgraded by analysts at William Blair to a "hold" rating.
11/14
07:49 pm
lyra
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
High
Report
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
11/14
05:49 pm
lyra
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Samsara BioCapital, L.P.
Medium
Report
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Samsara BioCapital, L.P.
11/14
05:49 pm
lyra
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.
Medium
Report
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.
11/14
04:55 pm
lyra
Form SCHEDULE 13G/A Lyra Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Lyra Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC
11/14
12:01 pm
lyra
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Vestal Point Capital, LP
Medium
Report
Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Vestal Point Capital, LP
11/12
04:25 pm
lyra
Form 10-Q Lyra Therapeutics, Inc. For: Sep 30
High
Report
Form 10-Q Lyra Therapeutics, Inc. For: Sep 30
11/12
04:19 pm
lyra
Form 8-K Lyra Therapeutics, Inc. For: Nov 12
High
Report
Form 8-K Lyra Therapeutics, Inc. For: Nov 12
10/18
04:05 pm
lyra
Form 4 Lyra Therapeutics, Inc. For: Oct 16 Filed by: Palasis Maria
Low
Report
Form 4 Lyra Therapeutics, Inc. For: Oct 16 Filed by: Palasis Maria
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register